Product liability lawsuits against the makers of the blood thinner Xarelto were among the fastest growing litigations in the United States for the period of February 16 to March 15, according to a Reuters analysis of statistics from the U.S. Judicial Panel on Multidistrict Litigation. Xarelto, known chemically as rivaroxaban, was approved by the Food and Drug Administration (FDA) in 2011. It is manufactured by Bayer and Johnson & Johnson’s Janssen Pharmaceuticals. Xarelto is indicated for the prevention of strokes in patients with atrial fibrillation, for the prevention and treatment of deep vein thrombosis and pulmonary embolism, and for the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.